Brown Advisory Inc. Invests $2.10 Million in U.S. Physical Therapy, Inc. (USPH) Stock

Share on StockTwits

Brown Advisory Inc. bought a new position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 21,819 shares of the company’s stock, valued at approximately $2,095,000. Brown Advisory Inc. owned about 0.17% of U.S. Physical Therapy at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of USPH. Kayne Anderson Rudnick Investment Management LLC increased its holdings in shares of U.S. Physical Therapy by 91.8% in the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 580,669 shares of the company’s stock valued at $47,208,000 after purchasing an additional 277,973 shares during the last quarter. BTIM Corp. acquired a new position in shares of U.S. Physical Therapy in the second quarter valued at $21,417,000. Riverbridge Partners LLC increased its holdings in shares of U.S. Physical Therapy by 45.6% in the second quarter. Riverbridge Partners LLC now owns 494,386 shares of the company’s stock valued at $47,461,000 after purchasing an additional 154,915 shares during the last quarter. BlackRock Inc. increased its holdings in shares of U.S. Physical Therapy by 6.4% in the second quarter. BlackRock Inc. now owns 1,748,408 shares of the company’s stock valued at $167,847,000 after purchasing an additional 104,499 shares during the last quarter. Finally, Carillon Tower Advisers Inc. acquired a new position in shares of U.S. Physical Therapy in the first quarter valued at $6,731,000. Institutional investors and hedge funds own 98.14% of the company’s stock.

USPH stock opened at $126.30 on Friday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.06 and a current ratio of 2.06. U.S. Physical Therapy, Inc. has a 52 week low of $57.80 and a 52 week high of $129.65. The stock has a market capitalization of $1.60 billion, a P/E ratio of 60.72, a price-to-earnings-growth ratio of 4.48 and a beta of 1.14.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Thursday, August 2nd. The company reported $0.73 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.68 by $0.05. U.S. Physical Therapy had a net margin of 5.03% and a return on equity of 13.81%. The business had revenue of $115.10 million for the quarter, compared to the consensus estimate of $111.77 million. During the same period in the prior year, the company posted $0.59 earnings per share. U.S. Physical Therapy’s revenue was up 10.4% compared to the same quarter last year. analysts predict that U.S. Physical Therapy, Inc. will post 2.51 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, September 7th. Investors of record on Tuesday, August 14th were paid a $0.23 dividend. The ex-dividend date was Monday, August 13th. This represents a $0.92 annualized dividend and a dividend yield of 0.73%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 44.23%.

In related news, Director Mark J. Brookner sold 4,375 shares of the company’s stock in a transaction dated Thursday, August 23rd. The shares were sold at an average price of $116.82, for a total value of $511,087.50. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Lawrance W. Mcafee sold 3,100 shares of the company’s stock in a transaction dated Friday, August 3rd. The shares were sold at an average price of $115.59, for a total transaction of $358,329.00. The disclosure for this sale can be found here. Insiders sold 28,929 shares of company stock worth $3,342,700 over the last 90 days. 2.50% of the stock is currently owned by corporate insiders.

Several research firms have commented on USPH. Jefferies Financial Group reiterated a “hold” rating and issued a $105.00 price objective on shares of U.S. Physical Therapy in a report on Friday, August 3rd. Zacks Investment Research downgraded shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Saturday, July 7th. ValuEngine upgraded shares of U.S. Physical Therapy from a “buy” rating to a “strong-buy” rating in a report on Tuesday, June 26th. Finally, Barrington Research restated a “hold” rating on shares of U.S. Physical Therapy in a research note on Friday, August 3rd. Five investment analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $99.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Article: Trading Strategy Examples and Plans

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply